The expression of cancer-related proteins regulated by formation of a G-quadruplex, including NRAS, can be effectively controlled if a ligand can not only bind reversibly but also attack irreversibly DNA and RNA G-quadruplexes. The gene discussed is NRAS; the disease is cancer.